The medical industry is navigating an exciting landscape marked by unprecedented demographic shifts, widespread technological advancement, surging medical expenses, and escalating risk of chronic diseases. This dynamic landscape presents a spectrum of opportunities for the companies operating within this space.
Given the promising backdrop, this article sheds light on the fundamentals of three sound medical stocks, Abbott Laboratories (ABT), Agilent Technologies, Inc. (A), and Viemed Healthcare, Inc. (VMD), which might be well-equipped to capitalize on the industry prospects.
